Joaquim Bellmunt-Molins - Publications

A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options.

Journal: BJU international

Published: November 17, 2010

New agents for bladder cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 15, 2010

A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 10, 2010

Expert opinion on the use of first-line sorafenib in selected metastatic renal cell carcinoma patients.

Journal: Expert review of anticancer therapy

Published: June 18, 2010

Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 17, 2010

Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06).

Journal: The Lancet. Oncology

Published: February 19, 2010

Experience with sorafenib and adverse event management.

Journal: Critical reviews in oncology/hematology

Published: February 03, 2010

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 19, 2009

New cell target treatments: indications, results and tolerance

Journal: Actas urologicas espanolas

Published: August 08, 2009

Future developments in renal cell carcinoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 12, 2009

Optimal management of metastatic renal cell carcinoma: an algorithm for treatment.

Journal: BJU international

Published: April 25, 2009

Impact of PSA implementation and combined radiation and hormonal therapy (RT+HT) on outcome of prostate cancer patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 05, 2009